From side effects to therapeutic combinations to consider, here is an update on the latest approaches to management of steroid-responsive dermatoses.
Ted Pigeon, Senior Associate Editor
As the incidence of non-melanoma skin cancer continues to rise, clinicians must be prepared to educate patients and refer for this curative and cost-effective intervention.
Alysa R. Herman, MD, Andrew J. Kaufman, MD, and Steven M. Rotter, MD
Seven years since the first biologic received approval for psoriasis, the expanding field remains promising. But questions remain.
Mark Bechtel, MD and Ann Bechtel, BSN
Meeting inventory challenges can help control costs and ensure consistent cash flow during economic difficulties.
Dana Jacoby and Mike Corvigno
Successful management of rosacea should target inflammation and barrier dysfunction in this increasingly common disease.
Joseph B. Bikowski, MD
Adoptive cell transfer is a potentially safe and effective future therapy for advanced melanoma.
Jonathan Wolfe, MD
Practitioners considering an investment in resurfacing lasers may benefit from this comparison of key system features.
Amina Husain, MD, Michael J. Richard, MD, and Julie A. Woodward, MD
The role of energy based devices for acne is slowly gaining acceptance among dermatologists. A variety of devices have been developed that address one or more aspects of acne.
Vic A. Narurkar, MD and Ava Shamban, MD